Literature DB >> 19054397

Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.

Nicole I Wolf1, Shamima Rahman, Bernhard Schmitt, Jan-Willem Taanman, Andrew J Duncan, Inga Harting, Gabriele Wohlrab, Friedrich Ebinger, Dietz Rating, Thomas Bast.   

Abstract

PURPOSE: Refractory convulsive status epilepticus in infancy and childhood is a rare emergency situation. Metabolic disorders frequently underlie this condition, in particular Alpers' disease caused by POLG1 mutations. Status epilepticus may be the first symptom. A pathognomonic electroencephalography (EEG) signature may facilitate diagnosis of Alpers' disease and allow timely avoidance of valproic acid, which is contraindicated in this disorder because it may trigger fatal liver failure. PATIENTS: We present five patients with Alpers' disease caused by mutations in POLG1. Age of onset ranged from 7 months to 10 years. Three of the five children died after 3 to 12 months after onset of status epilepticus. Two of these had liver failure associated with use of valproic acid; liver transplantation in one child did not prevent a fatal neurologic outcome.
RESULTS: Convulsive status epilepticus was the first obvious sign of Alpers' disease in all children. All had focal clonic and complex-focal seizures; four of them developed epilepsia partialis continua. In four children, initial EEG showed unilateral occipital rhythmic high-amplitude delta with superimposed (poly)spikes (RHADS). Magnetic resonance imaging (MRI) revealed cortical and thalamic involvement in all, although there were only discrete abnormalities in one child. Metabolic investigations remained normal in three children.
CONCLUSION: Alpers' disease is an important differential diagnosis in childhood refractory convulsive status epilepticus. Its EEG hallmark of RHADS is important for timely diagnosis, management, and counseling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19054397     DOI: 10.1111/j.1528-1167.2008.01877.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  30 in total

1.  Palliative functional hemispherectomy for treatment of refractory status epilepticus associated with Alpers' disease.

Authors:  Svetlana Lupashko; Saleem Malik; David Donahue; Angel Hernandez; M Scott Perry
Journal:  Childs Nerv Syst       Date:  2011-06-01       Impact factor: 1.475

2.  Epilepsy: MRI follow-up in paediatric convulsive status epilepticus.

Authors:  Rima Nabbout; Olivier Dulac
Journal:  Nat Rev Neurol       Date:  2012-04-17       Impact factor: 42.937

Review 3.  Alpers-Huttenlocher syndrome.

Authors:  Russell P Saneto; Bruce H Cohen; William C Copeland; Robert K Naviaux
Journal:  Pediatr Neurol       Date:  2013-03       Impact factor: 3.372

4.  Early-onset genetic epilepsies reaching adult clinics.

Authors:  David Lewis-Smith; Colin A Ellis; Ingo Helbig; Rhys H Thomas
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 5.  The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.

Authors:  Alessandro Orsini; Angelo Valetto; Veronica Bertini; Mariagrazia Esposito; Niccolò Carli; Berge A Minassian; Alice Bonuccelli; Diego Peroni; Roberto Michelucci; Pasquale Striano
Journal:  Seizure       Date:  2019-08-23       Impact factor: 3.184

6.  The Perirolandic Sign: A Unique Imaging Finding Observed in Association with Polymerase γ-Related Disorders.

Authors:  F G Gonçalves; B Hill; Y Guo; C C Muraresku; E McCormick; C A P F Alves; S R Teixeira; J S Martin-Saavedra; Z Zolkipli-Cunningham; M J Falk; A Vossough; A Goldstein; G Zuccoli
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-07       Impact factor: 3.825

Review 7.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

8.  Thalamus lesions in chronic and acute seizure disorders.

Authors:  Henriette J Tschampa; Susanne Greschus; Robert Sassen; Christian G Bien; Horst Urbach
Journal:  Neuroradiology       Date:  2010-06-29       Impact factor: 2.804

9.  Hypothermia for pediatric refractory status epilepticus.

Authors:  Kristin Guilliams; Max Rosen; Sandra Buttram; John Zempel; Jose Pineda; Barbara Miller; Michael Shoykhet
Journal:  Epilepsia       Date:  2013-08-01       Impact factor: 5.864

Review 10.  Gastrointestinal and hepatic manifestations of mitochondrial disorders.

Authors:  Shamima Rahman
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.